固体瘤中的抗体-药物联合体:一个新的前沿
Salvador Jaime-Casas1, Regina Barragan-Carrillo, Abhishek Tripathi
1Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Current opinion in oncology
|July 15, 2024
概括
抗体-药物合物 (ADC) 通过传递细胞毒性有效载荷,提供向癌症治疗. 本综述涵盖了固体瘤的已批准和正在研究的ADC,显示出有希望的结果和扩大治疗选择.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体与药物联合体 (ADC) 是一种针对癌症治疗的有针对性的方法.
- ADCs将细胞毒性有效载荷直接传递给瘤细胞,最大限度地降低全身毒性.
- 许多ADC正在开发和临床使用,用于各种癌症.
研究的目的:
- 为固体瘤批准和正在研究的ADC提供全面的概述.
- 突出目前的景观和ADC治疗在瘤学的未来方向.
主要方法:
- 审查目前已批准的ADCs.
- 在实体瘤的临床研究中分析ADC.
- 审查监管批准和生物标记物选择标准.
主要成果:
- 数十种抗癌药物正在对固体瘤进行临床评估,初步结果很有希望.
- 已批准的ADC向乳腺癌,非小细胞肺癌和膀癌.
- 批准包括生物标志物选择和泛癌症指示,其中一些独立于生物标志物表达.
结论:
- ADCs为传统的细胞毒性化疗提供了更有选择性的替代方案.
- 优化目标抗原选择,有效载荷传递和响应生物标志物是扩大ADC疗效的关键.
- 进一步的研究将加强ADC在各种固体瘤中的治疗益处.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509


